Genetic Polymorphisms of Glutathione S-transferase M1 and Bladder Cancer Risk: a Meta-analysis of 26 Studies

Overview

Journal Mol Biol Rep

Specialty Molecular Biology

Date 2010 Nov 18

PMID 21082260

Citations 12

Authors

Ronggui Zhang

Guangyong Xu

Wenjun Chen

Weili Zhang

Affiliations

Soon will be listed here.

Abstract

Studies investigating the association between glutathione S-transferase M1 (GSTM1) polymorphism and bladder cancer risk report conflicting results. The objective of this study was to quantitatively summarize the evidence for such a relationship. We performed a systematic search of the National Library of Medline and Embase databases. This meta-analysis included 26 case-control studies, which included 5029 bladder cancer cases and 6680 controls. The combined results based on all studies showed that the GSTM1 null genotype was associated with an increased risk of bladder cancer (OR=1.46, 95% confidence interval [CI]=1.35, 1.57). When stratifying for race, results were similar among Asians (OR=1.60, 95% CI=1.27, 2.01) and Caucasians (OR=1.44, 95% CI=1.33, 1.57) except Africans (OR=1.25, 95% CI=0.76, 2.06). When stratifying by the smoking, stage, grade, and histological type of bladder cancer, we found no statistical association. Our meta-analysis suggests that the GSTM1 null genotype is associated with a modest increase in the risk of bladder cancer.

Citing Articles

Genetic Polymorphisms Involved in Bladder Cancer: A Global Review.

Kourie H, Zouein J, Succar B, Mardirossian A, Ahmadieh N, Chouery E Oncol Rev. 2023; 17:10603.

PMID: 38025894 PMC: 10657888. DOI: 10.3389/or.2023.10603.

GSTM1 and GSTT1 polymorphisms are associated with increased bladder cancer risk: Evidence from updated meta-analysis.

Yu C, Hequn C, Longfei L, Long W, Zhi C, Feng Z Oncotarget. 2016; 8(2):3246-3258.

PMID: 27911277 PMC: 5356879. DOI: 10.18632/oncotarget.13702.

The relationship between GSTA1, GSTM1, GSTP1, and GSTT1 genetic polymorphisms and bladder cancer susceptibility: A meta-analysis.

Yu Y, Li X, Liang C, Tang J, Qin Z, Wang C Medicine (Baltimore). 2016; 95(37):e4900.

PMID: 27631264 PMC: 5402607. DOI: 10.1097/MD.0000000000004900.

Polymorphisms of NRF2 and NRF2 target genes in urinary bladder cancer patients.

Reszka E, Jablonowski Z, Wieczorek E, Jablonska E, Krol M, Gromadzinska J J Cancer Res Clin Oncol. 2014; 140(10):1723-31.

PMID: 24919441 PMC: 4160566. DOI: 10.1007/s00432-014-1733-0.

Association between glutathione S-transferase M1 null genotype and risk of gallbladder cancer: a meta-analysis.

Sun H, Han B, Zhai H, Cheng X, Ma K Tumour Biol. 2013; 35(1):501-5.

PMID: 24136740 DOI: 10.1007/s13277-013-1070-y.

References

Zendeh-Boodi Z, Saadat M . Genetic polymorphism of GSTT1 may be under natural selection in a population chronically exposed to natural sour gas. Mol Biol Rep. 2007; 35(4):673-6. DOI: 10.1007/s11033-007-9139-6. View

Ma Q, Lin G, Chen J, Shen J . Polymorphism of glutathione S-transferase T1, M1 and P1 genes in a Shanghai population: patients with occupational or non-occupational bladder cancer. Biomed Environ Sci. 2002; 15(3):253-60. View

Saadat I, Saadat M . Influence of genetic polymorphisms of glutathione S-transferase T1 (GSTT1) and M1 (GSTM1) on hematological parameters. Mol Biol Rep. 2009; 37(1):249-53. DOI: 10.1007/s11033-009-9662-8. View

Jeong H, Kim H, Seo I, Kim H, Oh G, Cheon Chae S . Association between glutathione S-transferase M1 and T1 polymorphisms and increased risk for bladder cancer in Korean smokers. Cancer Lett. 2003; 202(2):193-9. DOI: 10.1016/j.canlet.2003.09.007. View

Covolo L, Placidi D, Gelatti U, Carta A, Di Carlo A, Lodetti P . Bladder cancer, GSTs, NAT1, NAT2, SULT1A1, XRCC1, XRCC3, XPD genetic polymorphisms and coffee consumption: a case-control study. Eur J Epidemiol. 2008; 23(5):355-62. DOI: 10.1007/s10654-008-9238-2. View

Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T . Cancer statistics, 2008. CA Cancer J Clin. 2008; 58(2):71-96. DOI: 10.3322/CA.2007.0010. View

Rioja Zuazu J, Bandres Elizalde E, Rosell Costa D, Rincon Mayans A, Zudaire Bergera J, Gil Sanz M . [Steroid and xenobiotic receptor (SXR), multidrug resistance gene (MDR1) and GSTs, SULTs and CYP polymorphism expression in invasive bladder cancer, analysis of their expression and correlation with other prognostic factors]. Actas Urol Esp. 2008; 31(10):1107-16. DOI: 10.1016/s0210-4806(07)73772-5. View

McGrath M, Michaud D, De Vivo I . Polymorphisms in GSTT1, GSTM1, NAT1 and NAT2 genes and bladder cancer risk in men and women. BMC Cancer. 2006; 6:239. PMC: 1613249. DOI: 10.1186/1471-2407-6-239. View

Hung R, Boffetta P, Brennan P, Malaveille C, Hautefeuille A, Donato F . GST, NAT, SULT1A1, CYP1B1 genetic polymorphisms, interactions with environmental exposures and bladder cancer risk in a high-risk population. Int J Cancer. 2004; 110(4):598-604. DOI: 10.1002/ijc.20157. View

10.

Altayli E, Gunes S, Yilmaz A, Goktas S, Bek Y . CYP1A2, CYP2D6, GSTM1, GSTP1, and GSTT1 gene polymorphisms in patients with bladder cancer in a Turkish population. Int Urol Nephrol. 2008; 41(2):259-66. DOI: 10.1007/s11255-008-9444-6. View

11.

Karagas M, Park S, Warren A, Hamilton J, Nelson H, Mott L . Gender, smoking, glutathione-S-transferase variants and bladder cancer incidence: a population-based study. Cancer Lett. 2005; 219(1):63-9. DOI: 10.1016/j.canlet.2004.10.006. View

12.

Sobti R, Al-Badran A, Sharma S, Sharma S, Krishan A, Mohan H . Genetic polymorphisms of CYP2D6, GSTM1, and GSTT1 genes and bladder cancer risk in North India. Cancer Genet Cytogenet. 2004; 156(1):68-73. DOI: 10.1016/j.cancergencyto.2004.04.001. View

13.

Mittal R, Srivastava D, A M, B M . Genetic polymorphism of drug metabolizing enzymes (CYP2E1, GSTP1) and susceptibility to bladder cancer in North India. Asian Pac J Cancer Prev. 2005; 6(1):6-9. View

14.

Saad A, OConnor P, Mostafa M, Metwalli N, Cooper D, Povey A . Glutathione S-transferase M1, T1 and P1 polymorphisms and bladder cancer risk in Egyptians. Int J Biol Markers. 2005; 20(1):69-72. DOI: 10.5301/jbm.2008.829. View

15.

Kellen E, Zeegers M, Paulussen A, Vlietinck R, Vlem E, Veulemans H . Does occupational exposure to PAHs, diesel and aromatic amines interact with smoking and metabolic genetic polymorphisms to increase the risk on bladder cancer?; The Belgian case control study on bladder cancer risk. Cancer Lett. 2006; 245(1-2):51-60. DOI: 10.1016/j.canlet.2005.12.025. View

16.

Zupa A, Sgambato A, Bianchino G, Improta G, Grieco V, La Torre G . GSTM1 and NAT2 polymorphisms and colon, lung and bladder cancer risk: a case-control study. Anticancer Res. 2009; 29(5):1709-14. View

17.

Moore L, Malats N, Rothman N, Real F, Kogevinas M, Karami S . Polymorphisms in one-carbon metabolism and trans-sulfuration pathway genes and susceptibility to bladder cancer. Int J Cancer. 2007; 120(11):2452-8. DOI: 10.1002/ijc.22565. View

18.

Masoudi M, Saadat I, Omidvari S, Saadat M . Genetic polymorphisms of GSTO2, GSTM1, and GSTT1 and risk of gastric cancer. Mol Biol Rep. 2008; 36(4):781-4. DOI: 10.1007/s11033-008-9245-0. View

19.

La Torre G, Boccia S, Ricciardi G . Glutathione S-transferase M1 status and gastric cancer risk: a meta-analysis. Cancer Lett. 2004; 217(1):53-60. DOI: 10.1016/j.canlet.2004.08.020. View

20.

Toruner G, Akyerli C, Ucar A, Aki T, Atsu N, Ozen H . Polymorphisms of glutathione S-transferase genes (GSTM1, GSTP1 and GSTT1) and bladder cancer susceptibility in the Turkish population. Arch Toxicol. 2002; 75(8):459-64. DOI: 10.1007/s002040100268. View